| Literature DB >> 29458407 |
Felix Bolinski1,2, Annet Kleiboer3,4, Eirini Karyotaki3,4, Judith E Bosmans5, Anna-Carlotta Zarski6, Kiona K Weisel6, David D Ebert6, Corinna Jacobi7, Pim Cuijpers3,4, Heleen Riper3,4.
Abstract
BACKGROUND: Depression and anxiety are common and co-morbid disorders that affect a significant proportion of students. Innovative prevention strategies targeting both conditions are needed to reduce their health burden and costs. ICare Prevent is such an innovative strategy and contains a transdiagnostic individually tailored Internet-based and mobile-supported intervention. It addresses common risk factors of depression and anxiety as part of a large EU-funded multi-country project* (ICare). Little is known about the clinical and cost-effectiveness of this type of intervention compared to care as usual (CAU) for college students. We hypothesize that ICare Prevent will be more (cost-)effective than CAU in the reduction of symptoms of depression and anxiety.Entities:
Keywords: Anxiety; Cognitive behavioral therapy; Depression; Internet-based intervention; Prevention; Randomized controlled trial; Students
Mesh:
Year: 2018 PMID: 29458407 PMCID: PMC5819200 DOI: 10.1186/s13063-018-2477-y
Source DB: PubMed Journal: Trials ISSN: 1745-6215 Impact factor: 2.279
Fig. 1Study flowchart
Overview of topics covered by the intervention per session
| Session | Topic |
|---|---|
| 1 | Introduction, technical aspects, goal-setting, and behavioral activation in the context of basic psychological needs and important personal values |
| 2 | Identifying problems and tackling them through behavioral activation |
| 3 | Psychoeducation on depression and anxiety |
| 4 | Cognitive restructuring and challenging negative thoughts |
| 5 | Identifying the most prominent complaints and accordingly follow either: |
| a) problem-solving strategies for more prominent depressive complaintsb) exposure strategies for more prominent anxiety complaints | |
| 6 | Deepening the training on the route chosen in session 5 |
| 7 | Making a plan for the future |
| 8 | Booster session (four weeks after session 7) |
Overview of topics covered by the choice modules and diaries
| Choice module | Topic |
| 1 | Sleep |
| 2 | Perfectionism |
| 3 | Gratitude |
| 4 | Self-esteem |
| 5 | Alcohol consumption (includes AUDIT-C) |
| 6 | Relaxation |
| 7 | Acceptance |
| 8 | Rumination |
| Diary | Topic |
| 1 | Positive activities |
| 2 | Negative thoughts |
| 3 | Sleep |
| 4 | Challenging situations |
| 5 | Alcohol consumption |
Overview of instruments with associated assessment points
| Measure (instrument) | Assessment point | |||||
|---|---|---|---|---|---|---|
| T0 | T1 | T2 | T3 | T4 | T5 | |
| Screening | ||||||
| Depression (CES-D) | X | |||||
| Anxiety (GAD-7) | X | X | X | X | X | |
| Demographic data | X | |||||
| Mental disorder diagnosis self-reported | X | |||||
| Experience with psychotherapy | X | |||||
| Clinical diagnosis (M.I.N.I.) | X | X | X | |||
| Primary outcomes | ||||||
| Depression (QIDS) | X | X | X | X | ||
| Anxiety (SIGH-A) | X | X | X | X | ||
| Secondary outcomes | ||||||
| Depression (PHQ-9) | X | X | X | X | X | |
| Anxiety (GAD-7) | X | X | X | X | X | |
| Clinical diagnosis (M.I.N.I.) | X | X | X | |||
| Academic performance (PSS, ECTS) | X | X | X | X | X | |
| Cost-effectiveness | ||||||
| Costs (CSRI) | X | X | X | |||
| Other outcomes | ||||||
| Alcohol use (AUDIT-C) | X | X | X | X | X | |
| Alliance (WAI-SR)a | X | |||||
| Behavioral activation (BADS-SF) | X | X | X | X | ||
| Reasons for dropouta | X | |||||
| Expectations (CEQ) | X | |||||
| Incongruence (INKK) | X | X | X | X | ||
| Motivation (TEQ) | X | X | X | |||
| Negative effects of treatment (INEP)a | X | |||||
| Personality (BFI-10) | X | |||||
| Potential risk factorsb | X | |||||
| Program evaluation (CSQ-8)a | X | X | ||||
| Quality of life (AQoL, EQ-5D-8 L) | X | X | X | X | ||
| Resilience (CD-RISC) | X | X | X | X | X | |
| Sleep quality (PSQI) | X | X | X | X | ||
| Supporta | X | |||||
| Wellbeing (WHO-5) | X | X | X | X | ||
| Worry (PSWQ-3) | X | X | X | X | ||
aOnly in intervention groups
bOptional
T0 screening, T1 baseline, T2 after completion of session 5 or 5 weeks after randomization, T3 post intervention, T4 6-month follow-up, T5 12-month follow-up